Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study

Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study

BackgroundInterferon in combination with ribavirin has been the standard of care for chronic hepatitis C virus infection (HCV) for the past few decades. However, its effect on the risk of autoimmune diseases (ADs) among patients with HCV infection remains unclear. We assessed the potential associati...

Full description

Bibliographic Details
Main Authors: Shu-Ming Chou, Hsing-Jung Yeh, Tzu-Min Lin, Yu-Sheng Chang, Hui-Ching Hsu, Yu-Chuan Shen, Tzu-Tung Kuo, Jin-Hua Chen, Shu-Chuan Chen, Chi-Ching Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
hepatitis C virus
interferon-based therapy
autoimmune disease
Grave's disease
Hashimoto thyroiditis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.992819/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.992819/full

Similar Items